Published in J Hepatol on November 01, 1991
Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology (2008) 2.81
Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg (1999) 1.92
Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin. J Hepatol (2007) 1.74
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood (2007) 1.72
Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology (2015) 1.68
Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol (1996) 1.68
Non-invasive markers for hepatic fibrosis. BMC Gastroenterol (2011) 1.65
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C. Gut (2006) 1.59
Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest (2013) 1.57
Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol (2007) 1.47
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A (2007) 1.46
Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology (2010) 1.45
Infliximab-related hepatitis: a case study and literature review. Dig Dis Sci (2013) 1.43
Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut (2005) 1.28
Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol (2012) 1.21
Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. J Clin Pathol (2006) 1.21
Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol (2014) 1.20
Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut (1996) 1.17
Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology (2014) 1.14
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology (2010) 1.12
The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol (2002) 1.11
Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS One (2011) 1.09
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol (2003) 1.08
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology (2011) 1.07
The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3. Am J Pathol (2002) 1.07
Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models. Gastroenterology (2008) 1.07
Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol (2008) 1.06
Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol (2014) 1.05
Transcriptional repression of C4 complement by hepatitis C virus proteins. J Virol (2011) 1.04
Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol (2006) 1.02
Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats. Chin Med (2008) 1.02
The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy. PLoS One (2014) 1.01
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. J Virol (2010) 1.01
Non invasive tools for the diagnosis of liver cirrhosis. World J Gastroenterol (2014) 1.00
Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child (1992) 1.00
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Haematologica (2011) 1.00
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals. J Clin Pathol (2000) 1.00
Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance. J Viral Hepat (2010) 0.99
Hepatitis C virus induces the cannabinoid receptor 1. PLoS One (2010) 0.98
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial. World J Gastroenterol (2003) 0.95
Circulating microRNAs as a Fingerprint for Liver Cirrhosis. PLoS One (2013) 0.94
Gene expression analysis in serial liver fine needle aspirates. J Viral Hepat (2014) 0.93
Influence factors of serum fibrosis markers in liver fibrosis. World J Gastroenterol (2003) 0.93
Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways. Biochim Biophys Acta (2012) 0.92
Different Helicobacter hepaticus strains with variable genomic content induce various degrees of hepatitis. Infect Immun (2005) 0.92
The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. PLoS One (2014) 0.90
Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors. PLoS One (2010) 0.90
β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep (2014) 0.90
Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection. BMC Immunol (2012) 0.89
Antioxidants vitamin E and C attenuate hepatic fibrosis in biliary-obstructed rats. World J Gastroenterol (2006) 0.89
Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment. EBioMedicine (2016) 0.88
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut (2006) 0.88
Histological changes in chinese chronic hepatitis B patients with ALT lower than two times upper limits of normal. Dig Dis Sci (2009) 0.88
Hepatitis virus infection and liver disease in injecting drug users who died suddenly. J Clin Pathol (1996) 0.87
Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C. World J Gastroenterol (2014) 0.87
Liver fibrosis and tissue architectural change measurement using fractal-rectified metrics and Hurst's exponent. World J Gastroenterol (2006) 0.87
Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B. World J Gastroenterol (2004) 0.86
Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice. World J Gastroenterol (2014) 0.86
Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol (2009) 0.86
Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation. FASEB J (2012) 0.86
Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china. Hepat Mon (2013) 0.85
Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury. J Korean Med Sci (2010) 0.85
Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C. World J Gastroenterol (2004) 0.85
Huangqi decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosis. BMC Complement Altern Med (2012) 0.85
Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine. J Clin Immunol (2005) 0.84
Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies. Am J Surg Pathol (2011) 0.84
Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection. Clin Exp Immunol (2015) 0.83
Expression of bcl-2 protein in chronic hepatitis C: effect of interferon alpha 2b with ribavirin therapy. World J Gastroenterol (2005) 0.83
Liver injury in sepsis and abdominal compartment syndrome in rats. Surg Today (2006) 0.83
Inter-observer variability in histopathological assessment of liver biopsies taken in a pediatric open label therapeutic program for chronic HBV infection treatment. World J Gastroenterol (2006) 0.83
Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model. Exp Mol Med (2012) 0.83
Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV. PLoS One (2013) 0.83
The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China. Medicine (Baltimore) (2016) 0.83
Chronic hepatitis B: Enlarged perihepatic lymph nodes correlated with hepatic histopathology. World J Radiol (2013) 0.83
Proposed abdominal sonographic staging to predict severity of liver diseases: analysis with peritoneoscopy and histology. Dig Dis Sci (2000) 0.82
Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice. Gastroenterology (2011) 0.82
Plasma concentration of transforming growth factor-beta1 and hepatic fibrosis in dogs. Can J Vet Res (2008) 0.82
Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. PLoS One (2012) 0.82
Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3. PLoS One (2013) 0.82
Immunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathology. Am J Pathol (1993) 0.82
Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III. Dig Dis Sci (2001) 0.82
Diagnostic value of the C methacetin breath test in various stages of chronic liver disease. Gastroenterol Res Pract (2011) 0.82
Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats. BMC Complement Altern Med (2012) 0.82
Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial. World J Gastroenterol (2006) 0.82
Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C. World J Gastroenterol (2005) 0.82
SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C. Gut (2004) 0.82
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy. Medicine (Baltimore) (2016) 0.81
Proliferative ductular reactions correlate with hepatic progenitor cell and predict recurrence in HCC patients after curative resection. Cell Biosci (2014) 0.81
18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells. Med Sci Monit (2012) 0.81
Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat. Mol Cancer (2010) 0.81
Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy. Sci Rep (2015) 0.81
Correlation of Laparoscopic Liver Biopsy to Elasticity Measurements (FibroScan) in Patients With Chronic Liver Disease. Gastroenterol Hepatol (N Y) (2008) 0.81
Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk. Oncotarget (2015) 0.81
Effects of Haobie Yangyin Ruanjian decoction on hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol (2010) 0.81
Effects of Fufang Biejia Ruangan pills on hepatic fibrosis in vivo and in vitro. World J Gastroenterol (2013) 0.80